Docket Room
S 4355·Federal·senate

Drug Deal Disclosure Act

In CommitteeFiled Apr 21, 2026
Sponsor: Sen. Wyden, Ron [D-OR] (D)
Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Apr 21, 2026

Summary

The bill orders the Secretary of Health and Human Services to post, in a searchable online database, all records about MFN pricing deals and other confidential drug contracts with manufacturers that were signed on or after Jan. 20, 2025. It applies to agreements involving federal agencies and drug makers, and sets reporting and limited redaction rules. The aim is to give the public clearer insight into how drug prices are negotiated for Medicare, Medicaid and other programs.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when S 4355 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice